Anti-TRAP/SSP2 monoclonal antibodies can inhibit sporozoite infection and enhance protection of anti-CSP monoclonal antibodies
B. K. Wilder, V. Vigdorovich, S. Carbonetti, N. Minkah, N. Hertoghs, A. Raappana, H. Cardamone, B. G. Oliver, O. Trakhimets, S. Kumar, N. Dambrauskas, S. A. Arredondo, N. Camargo, S. H. I. Kappe, D. N. Sather
This study shows that anti-TRAP/SSP2 monoclonal antibodies inhibit sporozoite infection and enhance protection from CSP-based antibodies, suggesting a multivalent vaccine strategy could improve malaria vaccines.
bioRxiv · Oct 15, 2021 · PreprintMicrobiology